PharmaRadar360

PharmaRadar360

🌍·Sep 11Research

MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy

Publisher

N
Nature Cancer

Global

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Nature Cancer
Region
Global
Scope
Research
Published
September 11, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: Nature Cancer

Scope: Research

Open original article
MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy | PharmaRadar360